ArticleMolecular cancer therapeutics2008

STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.

H Dan Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.